US Stock MarketDetailed Quotes
GMAB Genmab
- 27.800
- -0.010-0.04%
Close Aug 30 16:00 ET
- 27.800
- 0.0000.00%
Post 20:01 ET
17.65BMarket Cap22.17P/E (TTM)
27.860High27.620Low347.19KVolume27.720Open27.810Pre Close9.63MTurnover0.06%Turnover Ratio28.37P/E (Static)634.94MShares38.80052wk High3.84P/B17.46BFloat Cap24.53052wk Low--Dividend TTM628.17MShs Float49.070Historical High--Div YieldTTM0.86%Amplitude16.240Historical Low27.740Avg Price1Lot Size
Genmab Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 247.02%1.51B | -53.23%1.51B | 88.65%7.38B | 320.10%1.67B | 3.51%2.04B | -54.54%436M | 451.11%3.24B | 75.58%3.91B | 65.15%398M | 340.27%1.97B |
| Net income from continuing operations | 25.56%2.13B | 545.11%1.72B | -18.83%5.64B | 61.89%926M | -15.92%2.75B | -31.94%1.69B | -56.54%266M | 77.26%6.95B | -36.51%572M | 179.42%3.27B |
| Operating gains losses | -791.67%-214M | -286.05%-627M | 258.93%596M | -51.68%1.03B | 40.00%-750M | 97.99%-24M | 610.61%337M | 51.98%-375M | 1,810.40%2.14B | -400.00%-1.25B |
| Depreciation and amortization | ---- | ---- | -18.51%295M | ---- | ---- | ---- | ---- | 45.97%362M | ---- | ---- |
| Other non cash items | -53.21%-596M | 3,400.00%35M | -200.99%-912M | -35.26%-959M | 219.85%435M | -372.03%-389M | -99.21%1M | -40.28%-303M | -61.14%-709M | 15.25%136M |
| Change In working capital | 53.03%-689M | -85.33%419M | 174.02%1.36B | 111.40%158M | 32.36%-186M | -185.96%-1.47B | 755.39%2.86B | -160.99%-1.84B | -2,817.65%-1.39B | 57.76%-275M |
| -Change in receivables | ---- | ---- | 137.54%797M | ---- | ---- | ---- | ---- | -110.41%-2.12B | ---- | ---- |
| -Change in inventory | ---- | ---- | ---57M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Change in payables and accrued expense | ---- | ---- | 119.79%622M | ---- | ---- | ---- | ---- | -6.91%283M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 247.02%1.51B | -53.23%1.51B | 88.65%7.38B | 320.10%1.67B | 3.51%2.04B | -54.54%436M | 451.11%3.24B | 75.58%3.91B | 65.15%398M | 340.27%1.97B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -378.04%-8.77B | -10,984.62%-1.44B | 53.57%-1.28B | -225.00%-442M | 172.94%1.01B | -218.58%-1.84B | 98.05%-13M | -187.30%-2.76B | 55.56%-136M | 14.74%-1.38B |
| Net PPE purchase and sale | 72.16%-27M | 73.08%-28M | -15.46%-366M | 39.09%-67M | -19.51%-98M | -42.65%-97M | -82.46%-104M | -25.79%-317M | -61.76%-110M | -6.49%-82M |
| Net intangibles purchase and sale | ---- | ---- | ---10M | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
| Net investment purchase and sale | 307.18%3.58B | -1,652.75%-1.41B | 62.93%-906M | -1,342.31%-375M | 185.08%1.11B | -240.16%-1.73B | 114.92%91M | -244.71%-2.44B | 89.08%-26M | 15.80%-1.3B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -378.04%-8.77B | -10,984.62%-1.44B | 53.57%-1.28B | -225.00%-442M | 172.94%1.01B | -218.58%-1.84B | 98.05%-13M | -187.30%-2.76B | 55.56%-136M | 14.74%-1.38B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -43,685.71%-3.05B | 2.62%-595M | 23.19%-606M | -116.79%-22M | 103.12%20M | 103.27%7M | -854.69%-611M | -87.86%-789M | 718.75%131M | -2,775.00%-642M |
| Net issuance payments of debt | 34.48%-19M | -14.29%-24M | -24.66%-91M | 3.85%-25M | 5.88%-16M | -107.14%-29M | -31.25%-21M | -25.86%-73M | -225.00%-26M | 19.05%-17M |
| Net common stock issuance | -14,376.19%-3.04B | -0.37%-545M | 37.89%-564M | --0 | --0 | 90.05%-21M | ---543M | -103.13%-908M | --0 | -6,870.00%-697M |
| Proceeds from stock option exercised by employees | -77.46%16M | 84.38%59M | -45.71%152M | -94.64%9M | -48.72%40M | 273.68%71M | 113.33%32M | 107.41%280M | 409.09%168M | 39.29%78M |
| Net other financing activities | 42.86%-8M | -7.59%-85M | -17.05%-103M | 45.45%-6M | 33.33%-4M | -75.00%-14M | -25.40%-79M | -76.00%-88M | -22.22%-11M | -500.00%-6M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -43,685.71%-3.05B | 2.62%-595M | 23.19%-606M | -116.79%-22M | 103.12%20M | 103.27%7M | -854.69%-611M | -87.86%-789M | 718.75%131M | -2,775.00%-642M |
| Net cash flow | ||||||||||
| Beginning cash position | 19.38%14.67B | 50.28%14.87B | 10.45%9.89B | 37.54%14.27B | 10.78%10.87B | 35.46%12.29B | 10.45%9.89B | 23.37%8.96B | 18.88%10.38B | 3.58%9.82B |
| Current changes in cash | -640.66%-10.31B | -120.03%-523M | 1,417.13%5.49B | 207.38%1.21B | 5,573.21%3.07B | -923.67%-1.39B | 1,913.19%2.61B | -57.26%362M | 902.04%393M | 95.13%-56M |
| Effect of exchange rate changes | -31.82%-29M | 250.93%326M | -190.24%-518M | 29.99%-614M | -45.87%334M | -103.82%-22M | -183.72%-216M | -32.47%574M | -416.61%-877M | 53.48%617M |
| End cash Position | -60.17%4.33B | 19.38%14.67B | 50.28%14.87B | 50.28%14.87B | 37.54%14.27B | 10.78%10.87B | 35.46%12.29B | 10.45%9.89B | 10.45%9.89B | 18.88%10.38B |
| Free cash flow | 351.67%1.49B | -52.57%1.49B | 94.83%7B | 457.29%1.61B | 2.81%1.94B | -63.08%329M | 490.75%3.13B | 81.93%3.6B | 66.47%288M | 409.73%1.89B |
| Currency Unit | DKK | DKK | DKK | DKK | DKK | DKK | DKK | DKK | DKK | DKK |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg